Matthew D Li1, Nils D Forkert2, Palak Kundu1, Cheryl Ambler3, Robert M Lober4, Terry C Burns5, Patrick D Barnes1, Iris C Gibbs6, Gerald A Grant5, Paul G Fisher7, Samuel H Cheshier5, Cynthia J Campen7, Michelle Monje7, Kristen W Yeom8. 1. Department of Radiology, Lucile Packard Children's Hospital, Stanford University, Stanford, CA. 2. Department of Radiology and Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada. 3. N.E.A.T. Private Practice, Los Altos, CA. 4. Department of Neurosurgery, Dayton Children's Hospital, Boonshoft School of Medicine, Dayton, OH. 5. Division of Pediatric Neurosurgery, Lucile Packard Children's Hospital, Stanford University School of Medicine, Stanford University, Stanford, CA. 6. Department of Radiation Oncology, Lucile Packard Children's Hospital, Stanford University, Stanford, CA. 7. Division of Pediatric Neurology, Department of Neurology, Lucile Packard Children's Hospital, Stanford University, Stanford, CA. 8. Department of Radiology, Lucile Packard Children's Hospital, Stanford University, Stanford, CA. Electronic address: kyeom@stanford.edu.
Abstract
OBJECTIVE: To compare cerebral perfusion and diffusion in survivors of childhood posterior fossa brain tumor with neurologically normal controls and correlate differences with cognitive dysfunction. STUDY DESIGN: We analyzed retrospectively arterial spin-labeled cerebral blood flow (CBF) and apparent diffusion coefficient (ADC) in 21 patients with medulloblastoma (MB), 18 patients with pilocytic astrocytoma (PA), and 64 neurologically normal children. We generated ANCOVA models to evaluate treatment effects on the cerebral cortex, thalamus, caudate, putamen, globus pallidus, hippocampus, amygdala, nucleus accumbens, and cerebral white matter at time points an average of 5.7 years after original diagnosis. A retrospective review of patient charts identified 12 patients with neurocognitive data and in whom the relationship between IQ and magnetic resonance imaging variables was assessed for each brain structure. RESULTS: Patients with MB (all treated with surgery, chemotherapy, and radiation) had significantly lower global CBF relative to controls (10%-23% lower, varying by anatomic region, all adjusted P?<?.05), whereas patients with PA (all treated with surgery alone) had normal CBF. ADC was decreased specifically in the hippocampus and amygdala of patients with MB and within the amygdala of patients with PA but otherwise remained normal after therapy. In the patients with tumor previously evaluated for IQ, regional ADC, but not CBF, correlated with IQ (R2?=?0.33-0.75). CONCLUSIONS: The treatment for MB, but not PA, was associated with globally reduced CBF. Treatment in both tumor types was associated with diffusion abnormalities of the mesial temporal lobe structures. Despite significant perfusion abnormalities in patients with MB, diffusion, but not perfusion, correlated with cognitive outcomes.
OBJECTIVE: To compare cerebral perfusion and diffusion in survivors of childhood posterior fossa brain tumor with neurologically normal controls and correlate differences with cognitive dysfunction. STUDY DESIGN: We analyzed retrospectively arterial spin-labeled cerebral blood flow (CBF) and apparent diffusion coefficient (ADC) in 21 patients with medulloblastoma (MB), 18 patients with pilocytic astrocytoma (PA), and 64 neurologically normal children. We generated ANCOVA models to evaluate treatment effects on the cerebral cortex, thalamus, caudate, putamen, globus pallidus, hippocampus, amygdala, nucleus accumbens, and cerebral white matter at time points an average of 5.7 years after original diagnosis. A retrospective review of patient charts identified 12 patients with neurocognitive data and in whom the relationship between IQ and magnetic resonance imaging variables was assessed for each brain structure. RESULTS:Patients with MB (all treated with surgery, chemotherapy, and radiation) had significantly lower global CBF relative to controls (10%-23% lower, varying by anatomic region, all adjusted P?<?.05), whereas patients with PA (all treated with surgery alone) had normal CBF. ADC was decreased specifically in the hippocampus and amygdala of patients with MB and within the amygdala of patients with PA but otherwise remained normal after therapy. In the patients with tumor previously evaluated for IQ, regional ADC, but not CBF, correlated with IQ (R2?=?0.33-0.75). CONCLUSIONS: The treatment for MB, but not PA, was associated with globally reduced CBF. Treatment in both tumor types was associated with diffusion abnormalities of the mesial temporal lobe structures. Despite significant perfusion abnormalities in patients with MB, diffusion, but not perfusion, correlated with cognitive outcomes.
Authors: Sarah J MacEachern; Jonathan D Santoro; Kara J Hahn; Zachary A Medress; Ximena Stecher; Matthew D Li; Jin S Hahn; Kristen W Yeom; Nils D Forkert Journal: Neuroradiology Date: 2019-12-18 Impact factor: 2.804
Authors: S M Toescu; P W Hales; J Cooper; E W Dyson; K Mankad; J D Clayden; K Aquilina; C A Clark Journal: AJNR Am J Neuroradiol Date: 2022-09-22 Impact factor: 4.966
Authors: Anders Wallin; Gustavo C Román; Margaret Esiri; Petronella Kettunen; Johan Svensson; George P Paraskevas; Elisabeth Kapaki Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Jan Petr; Louise Hogeboom; Pavel Nikulin; Evita Wiegers; Gwen Schroyen; Jesper Kallehauge; Marek Chmelík; Patricia Clement; Ruben E Nechifor; Liviu-Andrei Fodor; Philip C De Witt Hamer; Frederik Barkhof; Cyril Pernet; Maarten Lequin; Sabine Deprez; Radim Jančálek; Henk J M M Mutsaerts; Francesca B Pizzini; Kyrre E Emblem; Vera C Keil Journal: MAGMA Date: 2021-12-17 Impact factor: 2.310
Authors: Inga Harting; Murtadha Al-Saady; Ingeborg Krägeloh-Mann; Annette Bley; Maja Hempel; Tatjana Bierhals; Stephanie Karch; Ute Moog; Geneviève Bernard; Richard Huntsman; Rosalina M L van Spaendonk; Maaike Vreeburg; Agustí Rodríguez-Palmero; Aurora Pujol; Marjo S van der Knaap; Petra J W Pouwels; Nicole I Wolf Journal: Neurogenetics Date: 2020-01-15 Impact factor: 2.660